Article History
Accepted: 26 April 2022
First Online: 9 June 2022
Declarations
:
: No funding was received for the preparation of this article.
: S.B. Elmariah has served as a consultant, advisory board member, speaker, or investigator for Menlo Therapeutics, Trevi Therapeutics, Sanofi Regeneron, Galderma, RAPT Therapeutics, and Celldex Therapeutics. J.S. Smith has no relevant conflicts of interest. J.F. Merola is a consultant and/or investigator for Amgen, Bristol-Myers Squibb, AbbVie, Dermavant, Eli Lilly, Novartis, Janssen, UCB, Sanofi, Regeneron, Sun Pharma, Biogen, Pfizer Inc., and Leo Pharma.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: JSS, SBE, and JFM wrote the paper.